CHELALZProject ID: 656820
Financé au titre de:
Multitarget compounds with therapeutic potential against Alzheimer disease: Design and in vitro studies
Détails concernant le projet
Coût total:EUR 170 121,60
Contribution de l'UE:EUR 170 121,60
Appel à propositions:H2020-MSCA-IF-2014See other projects for this call
Régime de financement:MSCA-IF-EF-ST - Standard EF
This fellowship will provide a prolific researcher with an internationally competitive, multi-disciplinary research training at the Chemistry/Biology interface in an EU leading Bioinorganic chemistry team, preparing her to obtain her goal of a faculty position in the EU and her own research team in Medicinal Chemistry.
She will develop novel anti-Alzheimer conjugates that target multiple disease's hallmarks. Afterwards she will evaluate their in vitro therapeutic and diagnostic potential through a secondment with cell biologists in another EU country, the United Kingdom.
This research will pave the way towards the development of innovative and effective anti-Alzheimer drugs by using versatile drug combination approaches to fight this horrible and still incurable disease.
Alongside her research she will also acquire research management, leadership, presentation and teaching skills to prepare her for a successful future as an independent research group leader.
Contribution de l'UE: EUR 170 121,60
GRAN VIA DE LES CORTS CATALANES 585